275 related articles for article (PubMed ID: 9144789)
1. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
[TBL] [Abstract][Full Text] [Related]
2. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
Holdgate GA; Tunnicliffe A; Ward WH; Weston SA; Rosenbrock G; Barth PT; Taylor IW; Pauptit RA; Timms D
Biochemistry; 1997 Aug; 36(32):9663-73. PubMed ID: 9245398
[TBL] [Abstract][Full Text] [Related]
3. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
[TBL] [Abstract][Full Text] [Related]
4. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional model of Escherichia coli gyrase B subunit crystallized in two-dimensions on novobiocin-linked phospholipid films.
Celia H; Hoermann L; Schultz P; Lebeau L; Mallouh V; Wigley DB; Wang JC; Mioskowski C; Oudet P
J Mol Biol; 1994 Feb; 236(2):618-28. PubMed ID: 8107146
[TBL] [Abstract][Full Text] [Related]
6. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography.
Lewis RJ; Singh OM; Smith CV; Skarzynski T; Maxwell A; Wonacott AJ; Wigley DB
EMBO J; 1996 Mar; 15(6):1412-20. PubMed ID: 8635474
[TBL] [Abstract][Full Text] [Related]
7. Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the DNA gyrase B protein.
Lewis RJ; Singh OM; Smith CV; Maxwell A; Skarzynski T; Wonacott AJ; Wigley DB
J Mol Biol; 1994 Aug; 241(1):128-30. PubMed ID: 8051702
[TBL] [Abstract][Full Text] [Related]
8. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
Lafitte D; Lamour V; Tsvetkov PO; Makarov AA; Klich M; Deprez P; Moras D; Briand C; Gilli R
Biochemistry; 2002 Jun; 41(23):7217-23. PubMed ID: 12044152
[TBL] [Abstract][Full Text] [Related]
9. Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
Garrido SS; Scatigno AC; Trovatti E; Carvalho DC; Marchetto R
J Pept Res; 2005 May; 65(5):502-11. PubMed ID: 15853944
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of an N-terminal fragment of the DNA gyrase B protein.
Wigley DB; Davies GJ; Dodson EJ; Maxwell A; Dodson G
Nature; 1991 Jun; 351(6328):624-9. PubMed ID: 1646964
[TBL] [Abstract][Full Text] [Related]
11. Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein.
Blance SJ; Williams NL; Preston ZA; Bishara J; Smyth MS; Maxwell A
Protein Sci; 2000 May; 9(5):1035-7. PubMed ID: 10850814
[TBL] [Abstract][Full Text] [Related]
12. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
13. Transferred NOE and saturation transfer difference NMR studies of novobiocin binding to EnvZ suggest binding mode similar to DNA gyrase.
Plesniak LA; Botsch K; Leibrand M; Kelly M; Sem D; Adams JA; Jennings P
Chem Biol Drug Des; 2008 Jan; 71(1):28-35. PubMed ID: 18093089
[TBL] [Abstract][Full Text] [Related]
14. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
[TBL] [Abstract][Full Text] [Related]
15. The interaction between coumarin drugs and DNA gyrase.
Maxwell A
Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
[TBL] [Abstract][Full Text] [Related]
16. Installation of the pyrrolyl-2-carboxyl pharmacophore by CouN1 and CouN7 in the late biosynthetic steps of the aminocoumarin antibiotics clorobiocin and coumermycin A1.
Garneau-Tsodikova S; Stapon A; Kahne D; Walsh CT
Biochemistry; 2006 Jul; 45(28):8568-78. PubMed ID: 16834331
[TBL] [Abstract][Full Text] [Related]
17. Probing the binding of coumarins and cyclothialidines to DNA gyrase.
Kampranis SC; Gormley NA; Tranter R; Orphanides G; Maxwell A
Biochemistry; 1999 Feb; 38(7):1967-76. PubMed ID: 10026280
[TBL] [Abstract][Full Text] [Related]
18. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
Scatigno AC; Garrido SS; Marchetto R
J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
[TBL] [Abstract][Full Text] [Related]
19. The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes.
Kampranis SC; Howells AJ; Maxwell A
J Mol Biol; 1999 Oct; 293(3):733-44. PubMed ID: 10543963
[TBL] [Abstract][Full Text] [Related]
20. A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
Gevi M; Domenici E
Anal Biochem; 2002 Jan; 300(1):34-9. PubMed ID: 11743689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
